WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock

$52.88+1.64 (+3.2%)
Updated May 26, 2023
TXG Price
$52.88
Fair Value Price
$54.11
Market Cap
$6.14B
52 Week Low
$23.81
52 Week High
$58.30
P/E
-34.56x
P/B
7.66x
P/S
12.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$536.20M
Earnings
-$174.33M
Gross Margin
75.6%
Operating Margin
-31.62%
Profit Margin
-32.5%
Debt to Equity
0.26
Operating Cash Flow
-$17M
Beta
1.22
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TXG Overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TXG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TXG ($52.88) is undervalued by 2.28% relative to our estimate of its Fair Value price of $54.11 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TXG ($52.88) is not significantly undervalued (2.28%) relative to our estimate of its Fair Value price of $54.11 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TXG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TXG due diligence checks available for Premium users.

Be the first to know about important TXG news, forecast changes, insider trades & much more!

TXG News

Valuation

TXG fair value

Fair Value of TXG stock based on Discounted Cash Flow (DCF)
Price
$52.88
Fair Value
$54.11
Undervalued by
2.28%
TXG ($52.88) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TXG ($52.88) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TXG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TXG price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-34.56x
Industry
4.86x
Market
54.23x

TXG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.66x
Industry
3.29x
TXG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TXG's financial health

Profit margin

Revenue
$134.3M
Net Income
-$50.7M
Profit Margin
-37.8%
TXG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TXG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.0B
Liabilities
$211.6M
Debt to equity
0.26
TXG's short-term assets ($601.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TXG's short-term assets ($601.89M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TXG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.1M
Investing
$120.0M
Financing
-$3.4M
TXG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TXG vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
TXG$6.14B+3.20%-34.56x7.66x
DOCS$5.98B-1.57%52.95x6.19x
RCM$6.72B+1.52%-66.92x2.47x
HQY$4.67B-1.82%-177.74x2.46x
TDOC$3.71B-0.87%-0.52x1.62x

10x Genomics Stock FAQ

What is 10x Genomics's quote symbol?

(NASDAQ: TXG) 10x Genomics trades on the NASDAQ under the ticker symbol TXG. 10x Genomics stock quotes can also be displayed as NASDAQ: TXG.

If you're new to stock investing, here's how to buy 10x Genomics stock.

What is the 52 week high and low for 10x Genomics (NASDAQ: TXG)?

(NASDAQ: TXG) 10x Genomics's 52-week high was $58.30, and its 52-week low was $23.81. It is currently -9.29% from its 52-week high and 122.09% from its 52-week low.

How much is 10x Genomics stock worth today?

(NASDAQ: TXG) 10x Genomics currently has 116,192,123 outstanding shares. With 10x Genomics stock trading at $52.88 per share, the total value of 10x Genomics stock (market capitalization) is $6.14B.

10x Genomics stock was originally listed at a price of $52.75 in Sep 12, 2019. If you had invested in 10x Genomics stock at $52.75, your return over the last 3 years would have been 0.25%, for an annualized return of 0.08% (not including any dividends or dividend reinvestments).

How much is 10x Genomics's stock price per share?

(NASDAQ: TXG) 10x Genomics stock price per share is $52.88 today (as of May 26, 2023).

What is 10x Genomics's Market Cap?

(NASDAQ: TXG) 10x Genomics's market cap is $6.14B, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

10x Genomics's market cap is calculated by multiplying TXG's current stock price of $52.88 by TXG's total outstanding shares of 116,192,123.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.